Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 328 followers
Latest posts
Last updated 5 days ago
FDA grants Priority Review to Roche’s Gazyva/Gazyvaro for adults with primary membranous nephropathy
5 days ago
Priority Review decision is based on phase III MAJESTY results, where Gazyva/Gazyvaro...
Roche introduces cobas Hepatitis D Virus (HDV) test, the first fully automated diagnostic solution to identify the most severe form of viral hepatitis
6 days ago
The new test enables clinicians to reliably diagnose HDV and monitor patients’...
Roche receives CE Mark for blood test to identify tuberculosis infection
11 days ago
The Elecsys IGRA TB test expands global access to tuberculosis infection testing...
Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC
13 days ago
Five oral presentations in a Featured Research Session will highlight trontinemab, including...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s divarasib shows superiority in head-to-head phase III trial against approved KRAS G12C inhibitors in non-small cell lung cancer
18 days ago
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated...
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
20 days ago
The filing application is based on improvements seen across key efficacy endpoints...
Roche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
21 days ago
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost...
FDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
about 1 month ago
Filing acceptance based on data from the phase III SUNMO study where...
Roche receives FDA approval for the first companion diagnostic to assess PTEN protein in people living with prostate cancer
about 1 month ago
The new VENTANA PTEN (SP218) RxDx Assay fulfils an unmet medical need...
FDA grants Priority Review for Roche’s Tecentriq for a certain type of stage III colon cancer
about 1 month ago
Filing acceptance is based on the phase III Alliance ATOMIC study showing...
Roche announces global collaboration with Nurix Therapeutics to co-develop and co-commercialise potential best-in-class BTK degrader bexobrutideg across malignant haematology, immunology and neurology
about 1 month ago
Agreement offers potential best-in-class targeted protein degrader therapy option for people living...
FDA accepts New Drug Application for Roche’s giredestrant in ER-positive early-stage breast cancer, the first and only oral SERD with positive phase III results in the curative setting
about 2 months ago
Filing acceptance, under priority review, based on phase III data showing giredestrant...